Spruce Biosciences Prices Highly Dilutive $57.5M Public Offering at $50/Share
Summary
Spruce Biosciences has priced its public offering of 1,150,000 shares of common stock and pre-funded warrants at $50.00 per share. This offering is expected to raise $57.5 million. This follows the preliminary announcement of an underwritten public offering on April 20th. The capital raise is highly dilutive, representing approximately 60% of the company's current market capitalization, and comes after the company disclosed substantial doubt about its ability to continue as a going concern in its last 10-K. This significant dilution will likely exert considerable downward pressure on the stock price. Traders will be watching the market's reaction to the dilution and any further details on the use of proceeds.
At the time of this announcement, SPRB was trading at $60.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $95.9M. The 52-week trading range was $4.28 to $240.00. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.